{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,17]],"date-time":"2026-08-17T18:10:29Z","timestamp":1786990229073,"version":"build-2736575974"},"reference-count":28,"publisher":"Elsevier BV","issue":"11","license":[{"start":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T00:00:00Z","timestamp":1761955200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T00:00:00Z","timestamp":1761955200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/100005485","name":"American College of Cardiology","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100005485","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100005859","name":"Heart Rhythm Society","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100005859","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","heartrhythmjournal.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Heart Rhythm"],"published-print":{"date-parts":[[2025,11]]},"DOI":"10.1016\/j.hrthm.2024.11.050","type":"journal-article","created":{"date-parts":[[2024,11,28]],"date-time":"2024-11-28T09:24:23Z","timestamp":1732785863000},"page":"2877-2886","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":3,"title":["Long-term outcomes of subcutaneous versus transvenous implantable cardioverter defibrillator use among patients on maintenance dialysis"],"prefix":"10.1016","volume":"22","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-9896-8292","authenticated-orcid":false,"given":"Patrick H.","family":"Pun","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Li","family":"Qin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Karl E.","family":"Minges","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sana M.","family":"Al-Khatib","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniel J.","family":"Friedman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.hrthm.2024.11.050_bib1","series-title":"Epidemiology of Kidney Disease in the United States","year":"2023"},{"issue":"5","key":"10.1016\/j.hrthm.2024.11.050_bib2","doi-asserted-by":"crossref","first-page":"684","DOI":"10.1053\/j.ajkd.2016.12.006","article-title":"Sudden cardiac death among hemodialysis patients","volume":"69","author":"Makar","year":"2017","journal-title":"Am J Kidney Dis"},{"issue":"1","key":"10.1016\/j.hrthm.2024.11.050_bib3","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1186\/s12882-016-0293-8","article-title":"Incidence of sudden cardiac death in adults with end-stage renal disease: a systematic review and meta-analysis","volume":"17","author":"Ramesh","year":"2016","journal-title":"BMC Nephrol"},{"key":"10.1016\/j.hrthm.2024.11.050_bib4","doi-asserted-by":"crossref","DOI":"10.1161\/CIRCULATIONAHA.119.039818","article-title":"Prophylactic use of implantable cardioverter-defibrillators in the prevention of sudden cardiac death in dialysis patients: The prospective randomized controlled ICD2 trial","author":"Jukema","year":"2019","journal-title":"Circulation"},{"issue":"5","key":"10.1016\/j.hrthm.2024.11.050_bib5","doi-asserted-by":"crossref","first-page":"656","DOI":"10.1053\/j.ajkd.2007.02.272","article-title":"Increased complication rates of cardiac rhythm management devices in ESRD patients","volume":"49","author":"Dasgupta","year":"2007","journal-title":"Am J Kidney Dis"},{"issue":"11","key":"10.1016\/j.hrthm.2024.11.050_bib6","doi-asserted-by":"crossref","first-page":"1565","DOI":"10.1016\/j.hrthm.2009.08.006","article-title":"Clinical characteristics and in-hospital outcome of patients with end-stage renal disease on dialysis referred for implantable cardioverter-defibrillator implantation","volume":"6","author":"Aggarwal","year":"2009","journal-title":"Heart Rhythm"},{"issue":"1","key":"10.1016\/j.hrthm.2024.11.050_bib7","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1053\/j.ajkd.2015.01.028","article-title":"Subcutaneous implantable cardioverter defibrillator for dialysis patients: a strategy to reduce central vein stenoses and infections","volume":"66","author":"Dhamija","year":"2015","journal-title":"Am J Kidney Dis"},{"issue":"2","key":"10.1016\/j.hrthm.2024.11.050_bib8","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1007\/s10840-015-0093-2","article-title":"Outcomes of subcutaneous implantable cardioverter-defibrillator implantation in patients on hemodialysis","volume":"45","author":"Koman","year":"2016","journal-title":"J Interv Card Electrophysiol"},{"issue":"11","key":"10.1016\/j.hrthm.2024.11.050_bib9","doi-asserted-by":"crossref","first-page":"1050","DOI":"10.1016\/j.jacc.2021.12.033","article-title":"Longitudinal outcomes of subcutaneous or transvenous implantable cardioverter-defibrillators in older patients","volume":"79","author":"Friedman","year":"2022","journal-title":"J Am Coll Cardiol"},{"issue":"11","key":"10.1016\/j.hrthm.2024.11.050_bib10","doi-asserted-by":"crossref","first-page":"1622","DOI":"10.2215\/CJN.07920520","article-title":"Trends in use and in-hospital outcomes of subcutaneous implantable cardioverter defibrillators in patients undergoing long-term dialysis","volume":"15","author":"Pun","year":"2020","journal-title":"Clin J Am Soc Nephrol"},{"issue":"9","key":"10.1016\/j.hrthm.2024.11.050_bib11","doi-asserted-by":"crossref","first-page":"1340","DOI":"10.1016\/j.hrthm.2010.07.015","article-title":"Review of the registry's fourth year, incorporating lead data and pediatric ICD procedures, and use as a national performance measure","volume":"7","author":"Hammill","year":"2010","journal-title":"Heart Rhythm"},{"issue":"4","key":"10.1016\/j.hrthm.2024.11.050_bib12","doi-asserted-by":"crossref","first-page":"e59","DOI":"10.1016\/j.hrthm.2013.01.035","article-title":"The National ICD Registry Report: version 2.1 including leads and pediatrics for years 2010 and 2011","volume":"10","author":"Kremers","year":"2013","journal-title":"Heart Rhythm"},{"issue":"10","key":"10.1016\/j.hrthm.2024.11.050_bib13","doi-asserted-by":"crossref","first-page":"e190","DOI":"10.1016\/j.hrthm.2017.10.035","volume":"15","author":"Al-Khatib","year":"2018","journal-title":"Heart Rhythm"},{"issue":"6","key":"10.1016\/j.hrthm.2024.11.050_bib14","doi-asserted-by":"crossref","first-page":"643","DOI":"10.3747\/pdi.2012.00328","article-title":"Can dialysis patients be accurately identified using healthcare claims data?","volume":"34","author":"Taneja","year":"2014","journal-title":"Perit Dial Int"},{"issue":"1","key":"10.1016\/j.hrthm.2024.11.050_bib15","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1053\/j.ajkd.2018.01.034","article-title":"Medicare costs associated with arteriovenous fistulas among us hemodialysis patients","volume":"72","author":"Thamer","year":"2018","journal-title":"Am J Kidney Dis"},{"issue":"1","key":"10.1016\/j.hrthm.2024.11.050_bib16","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1093\/biomet\/asn055","article-title":"Dealing with limited overlap in estimation of average treatment effects","volume":"96","author":"Crump","year":"2009","journal-title":"Biometrika"},{"issue":"25","key":"10.1016\/j.hrthm.2024.11.050_bib17","doi-asserted-by":"crossref","first-page":"3083","DOI":"10.1002\/sim.3697","article-title":"Balance diagnostics for comparing the distribution of baseline covariates between treatment groups in propensity-score matched samples","volume":"28","author":"Austin","year":"2009","journal-title":"Stat Med"},{"issue":"3","key":"10.1016\/j.hrthm.2024.11.050_bib18","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1177\/0962280206074463","article-title":"Multiple imputation of discrete and continuous data by fully conditional specification","volume":"16","author":"van Buuren","year":"2007","journal-title":"Stat Methods Med Res"},{"issue":"3","key":"10.1016\/j.hrthm.2024.11.050_bib20","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1056\/NEJMoa043399","article-title":"Amiodarone or an implantable cardioverter-defibrillator for congestive heart failure","volume":"352","author":"Bardy","year":"2005","journal-title":"N Engl J Med"},{"issue":"5","key":"10.1016\/j.hrthm.2024.11.050_bib21","doi-asserted-by":"crossref","first-page":"829","DOI":"10.1093\/ndt\/gfu274","article-title":"Primary prevention implantable cardioverter defibrillators in end-stage kidney disease patients on dialysis: a matched cohort study","volume":"30","author":"Pun","year":"2015","journal-title":"Nephrol Dial Transplant"},{"issue":"3","key":"10.1016\/j.hrthm.2024.11.050_bib22","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1053\/j.ajkd.2011.03.026","article-title":"Trends in the use and outcomes of implantable cardioverter-defibrillators in patients undergoing dialysis in the United States","volume":"58","author":"Charytan","year":"2011","journal-title":"Am J Kidney Dis"},{"key":"10.1016\/j.hrthm.2024.11.050_bib23","doi-asserted-by":"crossref","DOI":"10.1016\/j.hrthm.2020.04.036","article-title":"Outcomes of subcutaneous implantable cardioverter-defibrillator in dialysis patients: results from the S-ICD post-approval study","author":"El-Chami","year":"2020","journal-title":"Heart Rhythm"},{"issue":"5","key":"10.1016\/j.hrthm.2024.11.050_bib24","doi-asserted-by":"crossref","first-page":"793","DOI":"10.1161\/CIRCEP.114.001455","article-title":"Survival after primary prevention implantable cardioverter-defibrillator placement among patients with chronic kidney disease","volume":"7","author":"Hess","year":"2014","journal-title":"Circ Arrhythm Electrophysiol"},{"issue":"4","key":"10.1016\/j.hrthm.2024.11.050_bib25","doi-asserted-by":"crossref","first-page":"1176","DOI":"10.3390\/jcm13041176","article-title":"Do implantable cardioverter-defibrillators prevent sudden cardiac death in end-stage renal disease patients on dialysis?","volume":"13","author":"Franczyk","year":"2024","journal-title":"J Clin Med"},{"issue":"3","key":"10.1016\/j.hrthm.2024.11.050_bib26","doi-asserted-by":"crossref","first-page":"382","DOI":"10.1016\/j.hrthm.2020.11.013","article-title":"Subcutaneous versus transvenous implantable defibrillator: an updated meta-analysis","volume":"18","author":"Rordorf","year":"2021","journal-title":"Heart Rhythm"},{"issue":"12","key":"10.1016\/j.hrthm.2024.11.050_bib27","doi-asserted-by":"crossref","first-page":"2036","DOI":"10.1093\/europace\/euw297","article-title":"Intermuscular technique for implantation of the subcutaneous implantable cardioverter defibrillator: long-term performance and complications","volume":"19","author":"Winter","year":"2017","journal-title":"Europace"},{"key":"10.1016\/j.hrthm.2024.11.050_bib28","doi-asserted-by":"crossref","DOI":"10.1007\/s10840-024-01767-1","article-title":"Subcutaneous cardioverter defibrillator implanted intermuscularly in patients with end-stage renal disease requiring hemodialysis: 5-year follow-up","author":"Kloppe","year":"2024","journal-title":"J Interv Card Electrophysiol"},{"issue":"14","key":"10.1016\/j.hrthm.2024.11.050_bib29","doi-asserted-by":"crossref","first-page":"1342","DOI":"10.1016\/j.jacc.2024.05.081","article-title":"Implantable cardioverter defibrillator and resynchronization therapy in patients with overt chronic kidney disease: JACC State-of-the-Art Review","volume":"84","author":"Varga","year":"2024","journal-title":"J Am Coll Cardiol"}],"container-title":["Heart Rhythm"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1547527124036348?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1547527124036348?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,5,15]],"date-time":"2026-05-15T18:03:24Z","timestamp":1778868204000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1547527124036348"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,11]]},"references-count":28,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2025,11]]}},"alternative-id":["S1547527124036348"],"URL":"https:\/\/doi.org\/10.1016\/j.hrthm.2024.11.050","relation":{},"ISSN":["1547-5271"],"issn-type":[{"value":"1547-5271","type":"print"}],"subject":[],"published":{"date-parts":[[2025,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Long-term outcomes of subcutaneous versus transvenous implantable cardioverter defibrillator use among patients on maintenance dialysis","name":"articletitle","label":"Article Title"},{"value":"Heart Rhythm","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.hrthm.2024.11.050","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 Heart Rhythm Society. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}]}}